Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "Bioburden Testing Market Size, Share and Trends Analysis Report by Product (Consumables, Instruments), Test, Application, End-use, and Region 2024-2030" ...

The most probable number (MPN) bioburden test method can be a valuable tool for determining bioburden counts when the typical bioburden test methods are problematic on a particular product or when a ...

New York, Nov. 04, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Bioburden Testing Market Research Report by Product, by Test, by Application, by End User - Global ...

The Global Bioburden Testing Market has experienced consistent growth, with a compound annual growth rate (CAGR) of 12-15%. This growth is driven by tightening regulatory standards and an increasing ...

Another driver contributing to the market growth is the growing emphasis on regulatory compliance. Regulatory authorities across the globe are imposing strict guidelines and regulations regarding ...

Lonza Pharma & Biotech and Innosieve Diagnostics announced today an exclusive distribution agreement for rapid bioburden testing technology. This agreement expands Lonza’s extensive offering of ...

Dublin, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The "Bioburden Testing Market - Forecasts from 2025 to 2030" report has been added to ResearchAndMarkets.com's offering. The Bioburden Testing Market is ...

Marketresearch.biz reports that the Bioburden Testing Market size is expected to be worth around USD 4.93 Billion by 2033, from USD 1.35 Billion in 2023, growing at a CAGR of 14.20% during the ...